Found 5 matching trials
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer PHASE2 RATIONALE: Monoclonal antibodies, such as cetuximab and bevacizumab, can bl...
Show More Location
Hopital Ambroise Pare
Learn More & Join Trial
Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases PHASE2 Patients presenting with multiple innumerable liver metastases will probabl...
Show More Location
Allgemeines Krankenhaus der Stadt Wien
Learn More & Join Trial
Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial PHASE2 Although resection provided survival benefit for selected HCC patients with...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases PHASE2 This is a multicentre, open-label, parallel-group, phase II-III, superiorit...
Show More Status
Active Not Recruiting
Location
Ziekenhuis Oost-Limburg
Learn More & Join Trial
Perioperative Treatment of Resectable Liver Metastases PHASE2 This randomized, controlled, multicenter, non-comparative phase II trial co...
Show More Location
Multiple Locations
Learn More & Join Trial